Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Sky One Moves to NASDAQ To Raise Brand Awareness

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Hoping to increase visibility with foreign investors, China Sky One Medical received approval to list its common stock on the NASDAQ Global Market, the company announced Sept. 2

You may also be interested in...



A Very Good Time For Acquisitions – China Sky One Sees Opportunities In Financial Crisis

SHANGHAI - China Sky One Medical will take the opportunity presented by the world financial crisis to look for companies to acquire with weak capital bases, the company's CEO says

A Very Good Time For Acquisitions – China Sky One Sees Opportunities In Financial Crisis

SHANGHAI - China Sky One Medical will take the opportunity presented by the world financial crisis to look for companies to acquire with weak capital bases, the company's CEO says

China Sky One Starts Shift From OTC To Prescription Market

SHANGHAI - China Sky One Medical entered 11 new drugs enter into clinical trials, seven of which are injectable drugs, the company announced June 10, which could lead to the company's first foray into the injectable drug market in China

UsernamePublicRestriction

Register

SC141576

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel